Skip to main content
Institute of Population Health Sciences (IPHS)

Dr Mohammad Talaei, MD MPH PhD

Mohammad

Postdoctoral Researcher

Email: m.talaei@qmul.ac.uk
Telephone: +44(0)20 7882 2499

Profile

Mohammad is an epidemiologist with research experiences in cardiometabolic diseases, aging, and recently respiratory disease. He gained his MD from Isfahan University of Medical Sciences (Iran) and his Master of Public Health (MPH) from the University of Birmingham (UK). From 2004 to 2013, he was the Director and PI of the Isfahan Cohort Study, a longitudinal study about cardiovascular disease risk factors. He received his PhD in nutritional epidemiology in 2017 from the National University of Singapore (Singapore). He has published over 60 papers in peer-reviewed journals and has a range of global experiences in epidemiological research. He works as a post-doctoral researcher with a special interest in the link between diet, atopic disease, and lung function in childhood.

Mohammad graduated from Isfahan University of Medical Sciences, Iran, with a Doctor of Medicine (MD) degree in 2004. He joined Isfahan Cardiovascular Research Institute as a researcher parallel to his clinical practice. In 2010, he gained his Master of Public Health (MPH with merit) from the University of Birmingham, UK, and returned to Iran to finalize his research projects. In 2013, he was granted the Singapore International Graduate Award (SINGA) scholarship for his PhD studies, a government-funded scheme to attract overseas graduates with a passion for research and excellent academic results. He received his PhD in December 2017 from the National University of Singapore, Singapore. Mohamad’s first-year postdoc was in Duke-NUS Medical School and Center for Healthy Aging, National University of Singapore. He joined to Institute of Population Health Sciences, Queen Mary University of London, in 2018 to pursue his research in the field of respiratory medicine.

Teaching

PBL tutor; OSCE examining

Research

Research Interests:

Mohamad’s principal research interests are in the etiology of cardiometabolic diseases, aging, and respiratory disease. Specifically, he investigates how risk factors, ranging from lifestyle to psychological factors, are related to these conditions using observational data from longitudinal epidemiological studies. He was the director (and PI) of Isfahan Cohort Study (ICS), a 10-year population based longitudinal study on over 6,500 individuals from urban and rural areas in central Iran and about cardiovascular disease and associated risk factors. His PhD project was based on Singapore Chinese Health Study, a longitudinal study of over 60,000 participants and 20 years of follow-up, with a special focus on nutritional epidemiology. As a nutritional epidemiologist, he has a range of interests in foods, nutrients, dietary patterns, and their corresponding biomarkers, with a special interest in gene-diet interactions. His current project is about the link between diet in middle childhood and respiratory and allergic outcomes in adolescence.

Publications

  1. Talaei M, Feng L, Barrenetxea J, Yuan JM, Pan A, Koh WP. Adiposity, weight change, and risk of cognitive impairment: The Singapore Chinese Health Study. J Alzheimers Dis. 2020 Feb 5. doi: 10.3233/JAD-191052.
  2. Talaei M, Feng L, Yuan JM, Pan A, Koh WP. Dairy, soy, and calcium consumption and risk of cognitive impairment: the Singapore Chinese Health Study. Eur J Nutr. 2019 Jun 3.
  3. Talaei M, Koh WP, Yuan JM, van Dam RM. DASH Dietary Pattern, Mediation by Mineral Intakes, and the Risk of Coronary Artery Disease and Stroke Mortality. J Am Heart Assoc. 2019 Mar 5;8(5):e011054
  4. Geng TT, Talaei M, Jafar TH, Yuan JM, Koh WP. Pulse Pressure and the Risk of End-Stage Renal Disease Among Chinese Adults in Singapore: The Singapore Chinese Health Study. J Am Heart Assoc. 2019 Dec 3;8(23):e013282
  5. Talaei M, Hosseini N, Koh AS, Yuan JM, Koh WP. Association of "Elevated Blood Pressure" and "Stage 1 Hypertension" With Cardiovascular Mortality Among an Asian Population. J Am Heart Assoc. 2018 Apr 10;7(8).
  6. Talaei M, Pan A, Yuan JM, Koh WP. Dairy intake and risk of type 2 diabetes. Clin Nutr. 2018 Feb;37(2):712-718.
  7. Talaei M, Hosseini N, van Dam RM, Sadeghi M, Oveisgharan S, Dianatkhah M, Sarrafzadegan N. Whole milk consumption and risk of cardiovascular disease and mortality: Isfahan Cohort Study. Eur J Nutr. 2017 Nov 18.
  8. Talaei M, Wang YL, Yuan JM, Pan A, Koh WP. Meat, dietary heme iron and risk of type 2 diabetes: The Singapore Chinese Health Study. Am J Epidemiol.  2017 Oct;186(7): 824–833.
  9. Talaei M§, Pan A, Yuan JM, Koh WP. Dairy Food Intake Is Inversely Associated with Risk of Hypertension: The Singapore Chinese Health Study. J Nutr. 2017 147: 235-241.
  10. Talaei M, Koh WP, Yuan JM, Pan A. The association between dairy product intake and cardiovascular disease mortality in Chinese adults. Eur J Nutr. 2017 Oct; 56(7): 2343-52
  11. Talaei M, Lee BL, Ong CN, van Dam RM, Yuan JM, Koh WP, Pan A. Urine phyto-oestrogen metabolites are not significantly associated with risk of type 2 diabetes: the Singapore Chinese health study. Br J Nutr. 2016 May;115(9):1607-15.
  12. Koh AS, Talaei M, Pan A, Wang R, Yuan JM, Koh WP. Systolic blood pressure and cardiovascular mortality in middle-aged and elderly adults - The Singapore Chinese Health Study. Int J Cardiol. 2016 Sep 15;219:404-9.
  13. Pan A, Wang Y, Talaei M, Hu FB, Wu T. Relation of active, passive, and quitting smoking with incident type 2 diabetes: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2015 Dec;3(12):958-67.
  14. Pan A, Wang Y, Talaei M, Hu FB. Relation of Smoking With Total Mortality and Cardiovascular Events Among Patients With Diabetes Mellitus: A Meta-Analysis and Systematic Review. Circulation. 2015 Nov 10;132(19):1795-804
  15. Talaei M, Koh WP, van Dam RM, Yuan JM, Pan A. Dietary soy intake is not associated with risk of cardiovascular disease mortality in Singapore Chinese adults. J Nutr. 2014 Jun;144(6):921-8.Talaei M, Sadeghi M, Marshall T, Thomas GN, Iranipour R, Nazarat N, Sarrafzadegan N. Anthropometric indices predicting incident type 2 diabetes in an Iranian population: the Isfahan Cohort Study. Diabetes Metab. 2013 Oct;39(5):424-31.
  16. Talaei M, Sadeghi M, Marshall T, Thomas GN, Iranipour R, Nazarat N, Sarrafzadegan N. Anthropometric indices predicting incident type 2 diabetes in an Iranian population: the Isfahan Cohort Study. Diabetes Metab. 2013 Oct;39(5):424-31.
  17. Talaei M, Sarrafzadegan N, Sadeghi M, Oveisgharan S, Marshall T, Thomas GN, Iranipour R. Incidence of cardiovascular diseases in an Iranian population: the Isfahan Cohort Study. Arch Iran Med. 2013 Mar;16(3):138-44.
  18. Talaei M, Mohammadifard N, Khaje MR, Sarrafzadegan N, Sajjadi F, Alikhasi H, Maghroun M, Iraji F, Ehteshami S. Healthy bread initiative: methods, findings, and theories--Isfahan Healthy Heart Program. J Health Popul Nutr. 2013 Mar;31(1):49-57.
  19. Roohafza H, Talaei M (co-first)§, Sadeghi M, Haghani P, Shokouh P, Sarrafzadegan N. Opium decreases the age at myocardial infarction and sudden cardiac death: a long- and short-term outcome evaluation. Arch Iran Med. 2013 Mar;16(3):154-60.
  20. Talaei M, Sadeghi M, Marshall T, Thomas GN, Kabiri P, Hoseini S, Sarrafzadegan N. Impact of metabolic syndrome on ischemic heart disease – a prospective cohort study in an Iranian adult population: Isfahan Cohort Study. Nutr Metab Cardiovasc Dis. 2012 May;22(5):434-41.
  21. Talaei M, Thomas GN, Marshall T, Sadeghi M, Iranipour R, Oveisgharan S, Sarrafzadegan N. Appropriate cut-off values of waist circumference to predict cardiovascular outcomes: 7-year follow-up in an Iranian population. Intern Med. 2012;51(2):139-46.
  22. For full list, please see: https://www.ncbi.nlm.nih.gov/myncbi/18s6m-j1k3/bibliography/public

 

ORCID ID: 0000-0002-6901-3665